期刊文献+

恶性脑胶质瘤术后三维适形放射治疗 被引量:1

Clinical analysis of postoperative 3-dimensional conformal radiotherapy for malignant gliomas
全文增补中
导出
摘要 目的探讨恶性脑胶质瘤术后三维适形放射治疗(3DCRT)的临床疗效及患者不良反应。方法将62例恶性脑胶质瘤术后患者随机分为两组,3DCRT 组32例,常规放疗组30例,照射剂量均为D_T 60 Gy/30次,6周。结果 3DCRT 组近期有效(CR+PR)率为87.5%(28/32),常规放疗组为73.3%(22/30),两组比较差异无统计学意义(P=0.158)。3DCRT 组1、2年生存率分别为90.6%(29/32)、81.3%(26/32),常规放疗组1、2年生存率分别为80%(24/30)、56.7%(17/30),两组间差异有统计学意义(P<0.05)。3DCRT 组放射性脑水肿发生率为15.6%(5/32),常规放疗组为40%(12/30),两组间差异有统计学意义(P<0.05)。放射性脑水肿经脱水治疗后好转,未发生严重并发症。主要死因是局部未控和肿瘤复发。结论恶性脑胶质瘤术后行3DCRT 比常规放疗有较好的疗效,其有较高的肿瘤局部控制率和1、2年生存率,无严重不良反应。 Objective To determine short-term therapeutic efficacy and side effect of postoperative 3-dimensional conformal radiotherapy for malignant glioma.Methods From January 2003 to January 2005, 62 patients with malignant glioma postoperation were randomized into two groups,32 entered in 3DCRT group and 30 entered in ordinary radiotherapy group.The dose of radiotherapy was 60 Gy/30 f, 6 weeks. Results The overall response rate in the 3DCRT group was 87.5 %(28/32),in the ordinary radiotherapy group was 73.3 %(22/30).There were no statistical significance(P=0.158).The survival rates at 1-,2-year were 90.6 % (29/32),81.3 %(26/32)in the 3DCRT group and 80 %(24/30),56.7 %(17/30)in the ordinary radiotherapy group. The difference was significant(P<0.05). The incidence of brain edema in the 3DCRT group was 15.6%(5/32),in the ordinary radiotherapy group was 40 %(12/30). The difference was significant(P<0.05). Brain edema were improved after dehydration therapy.No serious syndrome occurred. Primary dead causes were that local control defeated and tumor relapsed.Conclusion 3DCRT is more effective in the treatment for malignant glioma postoperation than ordinary radiotherapy.It has a high local control rate and 1-,2-year survival rate without serious side effect.
作者 陈刚
出处 《肿瘤研究与临床》 CAS 2007年第11期744-746,共3页 Cancer Research and Clinic
关键词 脑肿瘤 神经胶质瘤 放射治疗 计算机辅助 Brain neoplasms Glioma Radiotherapy,Computer-assisted
  • 相关文献

参考文献3

二级参考文献6

共引文献19

同被引文献15

  • 1周陈华,马胜林.脑胶质瘤的放射治疗进展[J].肿瘤研究与临床,2006,18(4):280-282. 被引量:14
  • 2Rosenthal MA, Ashley DM, Drummond KJ, et al. Brain stem gliomas: patterns of care in Victoria from 1998-2000. J Clin Neurosci, 2008, 15: 237-240.
  • 3Rosenthal MA, Drummond KJ, Dally M, et al. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust, 2006, 184: 270-273.
  • 4Langmoen IA, Lundar T, Storm-Mathisen I,et al. Management of pediatric pontine glioma. Childs Nerv Syst, 1991, 7: 13-15.
  • 5Zimmerman RA. Neuroimaging of primary brainstem gliomas: diagnosis and course. Pediatr Neurosurg, 1996, 25: 45-53.
  • 6Mursch K, Halatsch ME, Markakis E, et al. Intrinsic brainstem tumours in adults: results of microneurosurgical treatment of 16 consecutive patients. Br J Neurosurg, 2005, 19: 128-136.
  • 7Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol, 2006,7: 241-248.
  • 8Schulz-Ertner D, Debus J, Lohr F, et al. Fractionated stereotactic conformal radiation therapy of brain stem glioma: outcome and prognostic factors. Radiother Oncol, 2000, 57: 215-223.
  • 9Morris DE, Bourland JD, Rosenman JG, et al. Three-dimensional conformal radiation treatment planning and delivery for low- and intermediate-grade glioma. Semin Radiat Oncol, 2001,11: 124-137.
  • 10Doz F, Neuenschwander S, Bouffet E, et al. Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d'Oncologie P6diatrique. Eur J Cancer, 2002,38: 815-819.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部